Lepicortinolo (Prednisolone)

Prednisolone binds to intracellular glucocorticoid receptors, influencing gene transcription. This leads to increased production of anti‑inflammatory proteins and decreased synthesis of pro‑inflammatory cytokines, thereby dampening inflammation and modulating immune responses.

The dose of Lepicortinolo is individualized by the prescribing clinician based on the specific indication, severity of disease, patient weight, and response to therapy. Only a qualified healthcare professional should determine the appropriate regimen.

Safety data for prednisolone in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and decisions should be made in consultation with a healthcare provider.

To request Lepicortinolo, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Prednisolone is a medium‑potency glucocorticoid with a well‑characterized anti‑inflammatory profile. Compared with higher‑potency steroids like dexamethasone, it generally has a shorter half‑life and may be preferred when rapid tapering is anticipated, but the choice depends on clinical judgment and specific patient factors.

Lepicortinolo should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight to maintain stability.

Lepicortinolo is supplied as an injectable solution for intramuscular or intravenous administration. The route, injection site and infusion rate are determined by the prescribing clinician and should follow aseptic technique and institutional protocols.

Serious risks include severe infections due to immunosuppression, adrenal insufficiency if stopped abruptly, osteoporosis with long‑term use, gastrointestinal bleeding, and rare psychiatric effects such as psychosis. Patients should be monitored closely for these complications.

Lepicortinolo is contraindicated in patients with known hypersensitivity to prednisolone or any excipients, those with systemic fungal infections, and individuals receiving live vaccines. Caution is also advised for patients with uncontrolled diabetes, severe hypertension, or active peptic ulcer disease.